drugset / Trial / NCT07218744

Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants

NCT07218744

Phase 1 Completed 9 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

This study will assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of \[14C\] INCB123667 in healthy male participants.

Timeline

Start
2025-11-13
Primary completion
2025-12-10
Completion
2025-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB123667 Unknown Oral

Indications

No indication recorded.